The authors examine the effectiveness of an excipient comprised of mannitol, polyvinyl acetate, and crospovidone using model actives loperamide hydrogen chloride and caffeine.
S Kruse
Advertisement
S. Kruse, BASF
Articles by S Kruse
Advertisement
Latest Updated Articles
Development of Orally Disintegrating Tablets Based on a New ExcipientPublished: November 2nd 2008 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
PharmTech Weekly News Roundup – Week of November 3, 2025
5
